Clinical Trials Directory

Trials / Completed

CompletedNCT01992575

OCT in Retinal Vein Occlusions

Evaluation of the Utility of OCT Angiography in Assessing Vascular Perfusion in Retinal Vein Occlusions

Status
Completed
Phase
Study type
Observational
Enrollment
4 (actual)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Retinal blood vessel disease encompasses a wide variety of vision-threatening conditions. Of these conditions, retinal vein occlusions are the most common. Vision loss can occur as a result of macular ischemia (loss of blood flow to the macula) or macular edema (fluid build-up at the macula). OCT is an imaging technology that can perform non-contact cross-sectional imaging of retinal and choroidal tissue structures in real time. It is similar to ultrasound imaging, except that OCT measures the intensity of reflected light rather than sound waves. The purpose of this study is to see if non-invasive OCT technology can changes due to retinal vein occlusions as well as the more invasive fluorescein angiography, which requires an injection of dye into the vein of an arm of a patient. The study will also compare the mapping of blood vessels (angiography) and loss of blood flow (ischemia) by fluorescein angiography and OCT. These studies will be evaluated to see how they relate to vision loss.

Conditions

Timeline

Start date
2014-01-01
Primary completion
2018-08-21
Completion
2018-08-21
First posted
2013-11-25
Last updated
2024-02-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01992575. Inclusion in this directory is not an endorsement.